Nephrology
News, opinions and meeting coverage in nephrology.
— Balancing aspiration risk with the consequences of medication discontinuation
Latest in Nephrology
Standard of care prevails in single-center trial
More patients taking sodium zirconium cyclosilicate achieved normokalemia vs placebo recipients
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
Intranasal bumetanide demonstrated safety, bioequivalence with its oral and IV counterparts
Nephrology Case Studies
Consider metastatic or ectopic calcification in diagnosing unexplained symptoms in ESRD patients
Surgery had beneficial role
Lab tests, physical exam not helpful -- but history-taking offers a clue
More in Nephrology
Most are eligible for weight management indication
Accuracy above 85% in early testing -- far better than proteinuria and biopsy
One-time treatment with nexiguran ziclumeran tied to decline in serum TTR levels in phase I trial
SUMMIT trial able to show clinical benefit beyond quality-of-life improvement
BPROAD trial replicates SPRINT trial findings in diabetes population in China
Also in TTHealthWatch: frailty as a predictor of dementia
Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations
Plus: oral semaglutide outcomes and incident hypertension in teens on GLP-1 drugs
Researchers try to address challenge of distinguishing HCM from other cardiomyopathies
Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes
Health news and commentary gathered by staff
Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist
Diagnoses were also delayed the longer sugar was restricted
